When it comes to choosing stocks, it is perhaps a good idea to look into those stocks which may have recorded strong gains in the recent past and that principle brings us to the subject of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP).
The stock continued to be in focus among investors on Monday as it jumped by another 6% and thereby took its gains for the past week to as much as 15%. Although the gains are notable, investors need to also consider the little matter of the fact that there has been no material news about the company in the past week.
Hence, the rally might appear random and speculative to many investors. In this situation, it could be a good idea to remember that earlier on in the month on October 4 the clinical stage biopharmaceutical company had announced that it completed the acquisition of a new research and development centre.
The centre in question is located in Frederick, Md. The property, which stretches across an area of 48000 square foot, is going to be used by Tonix to expand its pipeline of products for infectious diseases. It is likely that the stock is going to continue to be in focus among investors this week.
